Outpacing Cancer

In the late 1990s the drug gefitinib became a new tool in treating the most common type of lung cancer, called non–small cell lung cancer. But doctors found that even with continued gefitinib treatment, some patients experienced a cancer relapse within a year. For the past several years, researchers have been working to uncover why these patients lost sensitivity to gefitinib and seeking how to overcome resistance to the drug. Kirsten Dorans reports on the strategies scientists are developing to outpace continually evolving cancer.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Druker, B.J. et al. Blood 94 (Suppl.), 368a (1999).

  2. 2

    Sawyers, C.L. N. Engl. J. Med. 340, 1330–1340 (1999).

  3. 3

    Shah, N.P. et al. Cancer Cell 2, 117–125 (2002).

  4. 4

    Talpaz, M. et al. N. Engl. J. Med. 354, 2531–2541 (2006).

  5. 5

    Kantarjian, H. et al. N. Engl. J. Med. 354, 2542–2551 (2006).

  6. 6

    Arteaga, C.L. Exp. Cell Res. 284, 122–130 (2003).

  7. 7

    Pao, W. et al. Proc. Natl. Acad. Sci. USA 101, 13306–13311 (2004).

  8. 8

    Lynch, T.J. et al. N. Engl. J. Med. 350, 2129–2139 (2004).

  9. 9

    Paez, J.G. et al. Science 304, 1497–1500 (2004).

  10. 10

    Pao, W. et al. PLoS Med. 2, e17 (2005).

  11. 11

    Kobayashi, S. et al. N. Engl. J. Med. 352, 786–792 (2005).

  12. 12

    Pao, W. et al. Proc. Natl. Acad. Sci. USA 2, e73 (2005).

  13. 13

    Costa, D.B. et al. PLoS Med. 4, 1669–1679 (2007).

  14. 14

    Balak, M.N. et al. Clin. Cancer Res. 12, 6494–6501 (2006).

  15. 15

    Bean, J. et al. Clin. Cancer Res. 14, 7519–7525 (2008).

  16. 16

    Bell, D.W. et al. Nat. Genet. 12, 1315–1316 (2005).

  17. 17

    Yun, C.H. et al. Proc. Natl. Acad. Sci. USA 105, 2070–2075 (2008).

  18. 18

    Engelman, J.A. et al. Science 316, 1039–1043 (2007).

  19. 19

    Bean, J. et al. Proc. Natl. Acad. Sci. USA 104, 20932–20937 (2007).

  20. 20

    Carter, T.A. et al. Proc. Natl. Acad. Sci. USA 102, 11011–11016 (2005).

  21. 21

    Maheswaran, S. et al. N. Engl. J. Med. 359, 366–377 (2008).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Dorans, K. Outpacing Cancer. Nat Med 15, 718–722 (2009). https://doi.org/10.1038/nm0709-718

Download citation

Further reading